INCYTE COVID-19 Response
Updated March 18, 2021
Incyte takes public health very seriously, and we are closely monitoring the evolving COVID-19 pandemic. Our primary focus is on ensuring patients have access to the medicines they need while safeguarding the health and safety of our employees.
See our responses to frequently asked questions below regarding how Incyte is responding to COVID-19. Please contact our support resources, listed below, for more information.